133 related articles for article (PubMed ID: 2779806)
1. [Venoruton and capillary permeability].
Cesarone MR; Laurora G; Gabini M; Errichi BM; Candiani C; Belcaro G
Minerva Cardioangiol; 1989 May; 37(5):265-8. PubMed ID: 2779806
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of capillary permeability and microcirculation in patients with chronic venous hypertension treated with venoruton by the vacuum suction chamber (VSC) device and laser-Doppler flowmetry.
Belcaro G; D'Aulerio A; Rulo A; Candiani C
Phlebologie; 1988; 41(4):847-56. PubMed ID: 3073400
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements.
Belcaro G; Rulo A; Candiani C
Vasa; 1989; 18(2):146-51. PubMed ID: 2662674
[TBL] [Abstract][Full Text] [Related]
4. Improvement of capillary permeability in patients with venous hypertension after treatment with TTFCA.
Belcaro GV; Grimaldi R; Guidi G
Angiology; 1990 Jul; 41(7):533-40. PubMed ID: 2389834
[TBL] [Abstract][Full Text] [Related]
5. The effect of hydroxyethylrutosides on capillary filtration in moderate venous hypertension: a double blind study.
Renton S; Leon M; Belcaro G; Nicolaides AN
Int Angiol; 1994 Sep; 13(3):259-62. PubMed ID: 7822903
[TBL] [Abstract][Full Text] [Related]
6. Capillary filtration in venous hypertension. Comparison between the vacuum suction chamber (VSC) device and straingauge phlethysmography.
Belcaro G; Rulo A; Renton S
Panminerva Med; 1992; 34(4):151-4. PubMed ID: 1293541
[TBL] [Abstract][Full Text] [Related]
7. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
[TBL] [Abstract][Full Text] [Related]
8. Capillary filtration in venous hypertension: evaluation with the vacuum suction chamber device and strain-gauge plethysmography.
Belcaro G; Rulo A; Cesarone MR; De Sanctis MT; Incandela L; Griffin M; Cacchio M
Angiology; 2001 Oct; 52 Suppl 2():S39-43. PubMed ID: 11666122
[TBL] [Abstract][Full Text] [Related]
9. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
[TBL] [Abstract][Full Text] [Related]
10. A study of the capillary permeability in patients with venous hypertension by a new system: the vacuum suction chamber (VSC) device.
Belcaro G; Candiani C; Errichi BM; Marinucci R; Gaspari AL; Lania M; Rulo A
Panminerva Med; 1988; 30(4):201-4. PubMed ID: 2977430
[No Abstract] [Full Text] [Related]
11. O-(beta-hydroxyethyl)-rutoside (Venoruton) fails to block histamine or bradykinin-induced edema formation in the canine forelimb perfused at constant arterial inflow.
Dobbins DE; Soika CY; Dabney JM
Microcirc Endothelium Lymphatics; 1984 Oct; 1(5):509-23. PubMed ID: 6546155
[TBL] [Abstract][Full Text] [Related]
12. [Capillary resistance raising action of Venoruton. Experimental data on the therapeutic effects of Venoruton].
Gábor M
Acta Pharm Hung; 1983 May; 53(3):115-20. PubMed ID: 6880764
[No Abstract] [Full Text] [Related]
13. [Kinetic effect characterization of 0-beta-hydroxyethylrutoside (Venoruton) in healthy probands].
Ott B; Rehn D; Nocker W; Diebschlag W
Vasa Suppl; 1991; 33():218. PubMed ID: 1788678
[No Abstract] [Full Text] [Related]
14. Treatment of acute superficial thrombosis and follow-up by computerized thermography.
Belcaro G; Errichi BM; Laurora G; Cesarone MR; Candiani C
Vasa; 1989; 18(3):227-34. PubMed ID: 2678804
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effects of elastic compression in patients with chronic venous hypertension by laser-Doppler flowmetry.
Belcaro G; Gaspari AL; Legnini M; Napolitano AM; Marelli C
Acta Chir Belg; 1988; 88(3):163-7. PubMed ID: 3051821
[TBL] [Abstract][Full Text] [Related]
16. HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Stuard S; Corsi M
Angiology; 2005; 56(2):165-72. PubMed ID: 15793606
[TBL] [Abstract][Full Text] [Related]
17. Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study.
Cesarone MR; Belcaro G; Ippolito E; Pellegrini L; Ledda A; Luzzi R; Ricci A; Dugall M; Bavera P; Hosoi M; Stuard S; Corsi M
Panminerva Med; 2010 Jun; 52(2 Suppl 1):43-8. PubMed ID: 20657534
[TBL] [Abstract][Full Text] [Related]
18. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Griffin M; Ippolito E; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S21-4. PubMed ID: 12011969
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of sudden deafness of vascular etiology with venoruton].
Madej S
Otolaryngol Pol; 1989; 43(3):214-7. PubMed ID: 2695884
[TBL] [Abstract][Full Text] [Related]
20. The effect of hydroxyethylrutosides on capillary filtration rate in the lower limb of man.
Roztocil K; Prerovský I; Oliva I
Eur J Clin Pharmacol; 1977 Jul; 11(6):435-8. PubMed ID: 891587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
